Precision BioSciences (DTIL)
(Delayed Data from NSDQ)
$9.82 USD
-0.41 (-4.01%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $9.98 +0.16 (1.63%) 6:36 PM ET
2-Buy of 5 2
C Value F Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.45 |
EPS Last Quarter | -3.35 |
Last EPS Surprise | -211.67% |
ABR | 1.80 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.93 |
Next Year | -2.87 |
EPS (TTM) | -16.26 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.35M | 6.75M | 30.10M | 27.80M |
# of Estimates | 2 | 2 | 2 | 2 |
High Estimate | 13.70M | 8.50M | 40.20M | 45.60M |
Low Estimate | 5.00M | 5.00M | 20.00M | 10.00M |
Year ago Sales | 8.78M | 19.79M | 48.73M | 30.10M |
Year over Year Growth Est. | 6.49% | -65.89% | -38.23% | -7.64% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.45 | -1.26 | -3.93 | -2.87 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.45 | -1.26 | -3.93 | -2.87 |
High Estimate | -0.45 | -1.26 | -3.93 | -2.87 |
Low Estimate | -0.45 | -1.26 | -3.93 | -2.87 |
Year ago EPS | -6.91 | -3.00 | -11.07 | -3.93 |
Year over Year Growth Est. | 93.49% | 58.00% | 64.50% | 26.97% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.45 | -1.26 | -3.93 | -2.87 |
7 Days Ago | -0.45 | -1.26 | -3.93 | -2.87 |
30 Days Ago | -1.80 | -1.80 | -6.31 | -3.90 |
60 Days Ago | -1.80 | -1.80 | -6.31 | -3.90 |
90 Days Ago | -1.80 | -1.80 | -6.31 | -3.90 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.45 | -1.26 | -3.93 | -2.87 |
Zacks Consensus Estimate | -0.45 | -1.26 | -3.93 | -2.87 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -3.35 | -3.00 | -3.00 | -6.91 | NA |
Estimate | 3.00 | -5.71 | -6.91 | -6.61 | NA |
Difference | -6.35 | 2.71 | 3.91 | -0.30 | -0.01 |
Surprise | -211.67% | 47.37% | 56.52% | -4.55% | -28.08% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more